Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer
2003 ◽
Vol 52
(2)
◽
pp. 125-130
◽
Keyword(s):
Phase Ii
◽